Correlation Between Champions Oncology and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Aerovate Therapeutics, you can compare the effects of market volatilities on Champions Oncology and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Aerovate Therapeutics.
Diversification Opportunities for Champions Oncology and Aerovate Therapeutics
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Champions and Aerovate is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Champions Oncology i.e., Champions Oncology and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Champions Oncology and Aerovate Therapeutics
Given the investment horizon of 90 days Champions Oncology is expected to generate 0.57 times more return on investment than Aerovate Therapeutics. However, Champions Oncology is 1.76 times less risky than Aerovate Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Aerovate Therapeutics is currently generating about 0.0 per unit of risk. If you would invest 607.00 in Champions Oncology on November 3, 2024 and sell it today you would earn a total of 492.00 from holding Champions Oncology or generate 81.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.6% |
| Values | Daily Returns |
Champions Oncology vs. Aerovate Therapeutics
Performance |
| Timeline |
| Champions Oncology |
| Aerovate Therapeutics |
Champions Oncology and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Champions Oncology and Aerovate Therapeutics
The main advantage of trading using opposite Champions Oncology and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
| Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |